Fund Holdings — Sarissa Capital Management LP

Total Portfolio Value:
$222.91M
Total Bought:
$8.79M
Total Sold:
$7.15M
Net Transaction:
+$1.64M
Securities
▲▼
SharesValue
Q3 2025
▲▼
Q4 2025
▲▼
Change
▲▼
Q3 2025
▲▼
Q4 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Innoviva, Inc.(INVA)2,816,0222,816,0220$51.39M$56.29M25.25%+$4.90M
Ironwood Pharmaceuticals, Inc.CL A(IRWD)15,919,43515,919,4350$20.85M$53.65M24.07%+$32.79M
Neurocrine Biosciences, Inc.(NBIX)303,151303,1510$42.56M$43.00M19.29%+$439.6K
Cytokinetics, Incorporated(CYTK)588,357396,357-192,000$32.34M$25.18M11.30%-$7.15M
Amarin Corp PlcADR1,242,5271,673,395+430,868$20.35M$23.35M10.48%+$3.00M
Lantheus Holdings, Inc.(LNTH)181,450181,4500$9.31M$12.08M5.42%+$2.77M
Biohaven Ltd.(BHVN)0513,184+513,184$0$5.79M2.60%+$5.79M
Regeneron Pharmaceuticals, Inc.(REGN)4,1904,1900$2.36M$3.23M1.45%+$878.2K
Vor Biopharma Inc.(VOR)25,39925,3990$1.24M$332.2K0.15%-$905.2K
Page 1 of 1
Sarissa Capital Management LP — 13F Holdings — Q4 2025 | TickerTrail